Mast cell effector function significantly influences the quantity, duration and magnitude of most allergic reactions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Traditionally, mast cells have been described as effector cells in IgE-associated immune response. However, mounting evidence describes a more complex model involving multiple mast cell phenotypes carrying out different functions and eliciting divergent effects on surrounding cells and tissue. Mast cells are involved in atopic disorders, often exacerbated by stress, and are located perivascularly close to sympathetic and sensory nerve endings. Mast cells represent an important source of pro-inflammatory mediators during acute, IgE-dependent reactions to allergen challenge, including those that contribute to the pathology of asthma and other allergic disorders. Allergy is the result of a complex immune cascade leading to the dysregulated production ofTh2 cytokines, the generation of allergen-specific IgE-producing B cells and the subsequent activation and degranulation of the mast cells upon allergen challenge (11) (12) . Evidences indicate that chronically relapsing inflammatory skin diseases such as atopic dermatitis and psoriasis are T cellmediated diseases. For this reason, understanding the underlying mechanisms of memory T-cell homing to the skin probably provide promising target for the development of new therapy to interfere with inflammatory processes of the skin.
Th 1 and Th2 T-helper cells express different cytokine patterns (11-13). Th I cells drive the type -I pathway: cellular immunity, to fight viruses and other intracellular pathogens, eliminate cancerous cells, stimulate delayed-type hypersensitivity (DTH) skin reactions and produce inflammatory cytokines (14) . Th2 cells drive the type-2 pathway: humoral immunity (14) , and up-regulate antibody production to fight extracellular organisms. Recently it has been reported that Th2 and Th I-type immune responses are not mutually exclusive, and that at least in some diseases a mixture of both Th2 and Th l occurs and the interactions between them account for the clinical characteristics of disease. There is also predominance of Th I cytokines, namely interferon gamma, in psoriatic plaques, in contrast to the predominance of Th2 cytokines found in atopic dermatitis. A number of requirements must be met if a chemical is to induce skin sensitization. The most important requirements are access to the viable epidermis, the formation of stable conjugates with proteins, elicitation of cytokine production by skin cells, and the initiation ofT cell responses (15) .
The immunological events that lead to allergic diseases are correlated with the activation of the T-helper 2 immune response (16) , the synthesis of the cytokines IL-4, IL-5, IL-13, and the inhibition of the T-helper 1 damages the capacity of the host to develop cytotoxic cells (17) . It has been reported that the majority of T cells in psoriatic plaque are CD45RO+ memory-effector T cells that migrate into skin in recognition of an as yet undetermined antigen (18) . Allergen immunotherapy results in a profound IgG and IgA response with downregulation of Th2 and possibly up-regulation of Th I responses through the increase of macrophages producing IL-12, a cytokine that supports the development of ThO into Thl CD4+ cells. It has been shown that IL-12 and IL-18 without TcR engagement can induce IFN-gamma in Thl cells and nonpolarized T cells. In addition a combination of IL-12 and IL-18 acts on B cells, NK cells, macrophages and dendritic cells to produce IFNgamma. In contrast, IL-18 without help from IL-12 induces Th2 cytokines in T cells and NK cells. IL-18 which requires cleavage with caspase-l to become active, directly stimulates basophils and mast cells to produce Th2 cytokines and histamine independently of IgE. Moreover, IL-18 causes high-level of IgE production by causing CD4+ T cells to produce IL-4 and to express CD40 ligand.
Macrophage-derived cytokine, a member of the CC chemokine family is upregulated by Th2type 2 cytokines, such as IL-4 and IL-5 and is down regulated by Th I-type cytokines such as IFN-gamma. This chemokine is chemotactic for Th2 cells and is highly expressed in Th2-related diseases, such as airway hypersensitivity and atopic dermatitis. Locally secreted chemokines might help to attract T cells through their corresponding chemokine receptors (19) (20) (21) (22) (23) (24) (25) (26) (27) . Specific memory T cells express various surface receptors such as the alpha4beta-integrin or the cutaneous lymphocyte antigens and specific chemokine receptors such as CCR4, CCR7 and CCR9.
Cytokines released in the skin strongly affects the expression of heat shock proteins (HSP) in epidermal cells. These proteins can be targets for infiltrated T cells to modulate immune response and may play an important role in the pathogenesis of many inflammatory skin diseases. However, only limited information is available on the role of HSP in the skin diseases.
